APA aipamena

Nguyen, T., Dai, Y., Attkisson, E., Kramer, L., Jordan, N., Nguyen, N., . . . Grant, S. (2011). HDAC INHIBITORS POTENTIATE THE ACTIVITY OF THE BCR/ABL KINASE INHIBITOR KW-2449 IN IMATINIB-SENSITIVE OR -RESISTANT BCR/ABL(+) LEUKEMIA CELLS IN VITRO AND IN VIVO.

Chicago Style aipamena

Nguyen, Tri, Yun Dai, Elisa Attkisson, Lora Kramer, Nicholas Jordan, Nguyen Nguyen, Nikhil Kolluri, Markus Muschen, and Steven Grant. HDAC INHIBITORS POTENTIATE THE ACTIVITY OF THE BCR/ABL KINASE INHIBITOR KW-2449 IN IMATINIB-SENSITIVE OR -RESISTANT BCR/ABL(+) LEUKEMIA CELLS IN VITRO AND IN VIVO. 2011.

MLA aipamena

Nguyen, Tri, et al. HDAC INHIBITORS POTENTIATE THE ACTIVITY OF THE BCR/ABL KINASE INHIBITOR KW-2449 IN IMATINIB-SENSITIVE OR -RESISTANT BCR/ABL(+) LEUKEMIA CELLS IN VITRO AND IN VIVO. 2011.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.